loading
Schlusskurs vom Vortag:
$63.29
Offen:
$63.64
24-Stunden-Volumen:
43,433
Relative Volume:
0.63
Marktkapitalisierung:
$424.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.98M
KGV:
-45.50
EPS:
-1.3177
Netto-Cashflow:
$-3.85M
1W Leistung:
+15.94%
1M Leistung:
+22.48%
6M Leistung:
+107.11%
1J Leistung:
+5,429%
1-Tages-Spanne:
Value
$58.64
$65.00
1-Wochen-Bereich:
Value
$48.94
$65.00
52-Wochen-Spanne:
Value
$1.11
$79.02

Bright Minds Biosciences Inc Stock (DRUG) Company Profile

Name
Firmenname
Bright Minds Biosciences Inc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
DRUG's Discussions on Twitter

Vergleichen Sie DRUG mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
DRUG
Bright Minds Biosciences Inc
60.32 448.64M 0 -4.98M -3.85M -1.3177
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.62 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
472.68 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
552.20 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
809.14 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
331.45 35.16B 4.56B -176.77M 225.30M -1.7177

Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-08 Eingeleitet BTIG Research Buy
2025-05-13 Eingeleitet TD Cowen Buy
2025-05-07 Eingeleitet Chardan Capital Markets Buy
2025-01-23 Eingeleitet Piper Sandler Overweight
2025-01-10 Eingeleitet Cantor Fitzgerald Overweight
2025-01-10 Eingeleitet H.C. Wainwright Buy
2024-11-26 Eingeleitet Robert W. Baird Outperform
Alle ansehen

Bright Minds Biosciences Inc Aktie (DRUG) Neueste Nachrichten

pulisher
10:27 AM

Will Bright Minds Biosciences Inc. outperform the marketJuly 2025 Spike Watch & Free Reliable Trade Execution Plans - newser.com

10:27 AM
pulisher
08:28 AM

Exit strategy if you’re trapped in Bright Minds Biosciences Inc.2025 Short Interest & Fast Moving Trade Plans - newser.com

08:28 AM
pulisher
03:34 AM

Visualizing Bright Minds Biosciences Inc. stock with heatmaps2025 Top Decliners & Low Risk Growth Stock Ideas - newser.com

03:34 AM
pulisher
Oct 12, 2025

Has Bright Minds Biosciences Inc. found a price floorJuly 2025 WrapUp & Entry Point Strategy Guides - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

Insiders Who Sold CA$17m Of Bright Minds Biosciences Made The Right Call - simplywall.st

Oct 11, 2025
pulisher
Oct 10, 2025

Published on: 2025-10-10 09:53:23 - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Risk vs reward if holding onto Bright Minds Biosciences Inc.Analyst Downgrade & Free Long-Term Investment Growth Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

How to use Fibonacci retracement on Bright Minds Biosciences Inc.July 2025 WrapUp & AI Enhanced Trading Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

What technical models suggest about Bright Minds Biosciences Inc.’s comebackQuarterly Earnings Summary & Reliable Intraday Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Regression analysis insights on Bright Minds Biosciences Inc. performanceMarket Performance Summary & AI Powered Market Entry Ideas - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Published on: 2025-10-09 04:28:20 - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives $81.00 Consensus Target Price from Analysts - Defense World

Oct 07, 2025
pulisher
Oct 05, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Stock Rating Lowered by Wall Street Zen - Defense World

Oct 05, 2025
pulisher
Oct 04, 2025

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Rating of "Buy" from Analysts - MarketBeat

Oct 04, 2025
pulisher
Oct 04, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Cut to Sell at Wall Street Zen - MarketBeat

Oct 04, 2025
pulisher
Oct 03, 2025

Will Bright Minds Biosciences Inc. stock outperform growth indexesJuly 2025 Pullbacks & Daily Market Momentum Tracking - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

BTIG Maintains Bright Minds Biosciences(DRUG.US) With Buy Rating, Maintains Target Price $72 - 富途牛牛

Oct 02, 2025
pulisher
Sep 30, 2025

Published on: 2025-09-30 11:54:24 - earlytimes.in

Sep 30, 2025
pulisher
Sep 28, 2025

What analysts say about Bright Minds Biosciences Inc stockResistance Zone Identification & High Return Investment Plans - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Is Bright Minds Biosciences Inc a good long term investmentMarket Liquidity Analysis & Explosive Capital Growth Plans - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

What drives Bright Minds Biosciences Inc stock priceAI-Driven Market Analysis & Low Risk Investment Growth - earlytimes.in

Sep 27, 2025
pulisher
Sep 26, 2025

Bright Minds Biosciences Inc Stock Analysis and ForecastCandlestick Pattern Analysis & Fast Profit Stock Ideas - Early Times

Sep 26, 2025
pulisher
Sep 25, 2025

H.C. Wainwright Maintains Bright Minds Biosciences(DRUG.US) With Buy Rating, Maintains Target Price $85 - 富途牛牛

Sep 25, 2025
pulisher
Sep 24, 2025

Goldman Sachs Group Inc. Takes Position in Bright Minds Biosciences Inc. $DRUG - Defense World

Sep 24, 2025
pulisher
Sep 23, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Rating Increased to Hold at Wall Street Zen - MarketBeat

Sep 23, 2025
pulisher
Sep 22, 2025

Relative strength of Bright Minds Biosciences Inc. in sector analysisProduct Launch & Stepwise Entry/Exit Trade Alerts - newser.com

Sep 22, 2025
pulisher
Sep 20, 2025

Using data filters to optimize entry into Bright Minds Biosciences Inc.July 2025 Gainers & Precise Buy Zone Identification - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Upgraded by Wall Street Zen to Hold Rating - Defense World

Sep 20, 2025
pulisher
Sep 19, 2025

Chart based analysis of Bright Minds Biosciences Inc. trendsEarnings Trend Report & High Accuracy Trade Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Portfolio Update: How is Bright Minds Biosciences Inc managing supply chain issues2025 Winners & Losers & Free High Return Stock Watch Alerts - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

How to forecast Bright Minds Biosciences Inc. trends using time seriesOptions Play & Fast Gain Stock Trading Tips - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

What data driven models say about Bright Minds Biosciences Inc.’s futureMarket Performance Report & Verified Short-Term Trading Plans - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

HC Wainwright Reaffirms "Buy" Rating for Bright Minds Biosciences (NASDAQ:DRUG) - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Aug Sectors: What is HIPOs 5 year growth outlookEarnings Performance Report & Technical Pattern Based Signals - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

S P Trends: What is Bright Minds Biosciences Inc. s revenue forecast2025 Biggest Moves & Precise Buy Zone Tips - خودرو بانک

Sep 19, 2025
pulisher
Sep 18, 2025

Wall Street Analysts Believe Bright Minds Biosciences Inc. (DRUG) Could Rally 81.29%: Here's is How to Trade - Yahoo Finance

Sep 18, 2025
pulisher
Sep 18, 2025

Bright Minds Biosciences Reports Q3 2025 Financial Results - MSN

Sep 18, 2025
pulisher
Sep 17, 2025

Growth Report: Is Driven Brands Holdings Inc. undervalued by DCF analysisJuly 2025 Weekly Recap & High Conviction Trade Alerts - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Bright Minds rebounds after $35M private placement - MSN

Sep 17, 2025
pulisher
Sep 16, 2025

Will Bright Minds Biosciences Inc benefit from rate cutsJuly 2025 Final Week & Short-Term High Return Strategies - خودرو بانک

Sep 16, 2025

Finanzdaten der Bright Minds Biosciences Inc-Aktie (DRUG)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Bright Minds Biosciences Inc-Aktie (DRUG) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Cormorant Asset Management, LP
10% Owner
Oct 15 '24
Buy
5.53
372,591
2,061,574
825,000
Cormorant Asset Management, LP
10% Owner
Oct 16 '24
Buy
23.46
50,000
1,172,813
875,000
$84.69
price up icon 1.10%
$22.76
price up icon 6.16%
$32.50
price up icon 2.17%
$102.23
price up icon 0.32%
$166.15
price up icon 2.29%
biotechnology ONC
$331.45
price up icon 3.60%
Kapitalisierung:     |  Volumen (24h):